Vikram Deshpande Selected Research

Vikram Deshpande Research Topics

Disease

105	Neoplasms (Cancer) 11/2022 - 04/2003
33	Adenocarcinoma 11/2022 - 12/2006
28	Immunoglobulin G4-Related Disease 10/2022 - 10/2007
17	Neoplasm Metastasis (Metastasis) 11/2022 - 03/2010
15	Cholangiocarcinoma 01/2022 - 01/2012
13	Fibrosis (Cirrhosis) 12/2021 - 05/2011
12	Inflammation (Inflammations) 01/2022 - 10/2007
12	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 09/2012
10	Autoimmune Pancreatitis 01/2019 - 12/2006
9	Carcinoma (Carcinomatosis) 11/2022 - 05/2007
5	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 06/2013
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 03/2008
4	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2017
4	Virus Diseases (Viral Diseases) 01/2022 - 08/2020
4	COVID-19 12/2021 - 08/2020
4	Chordoma 01/2021 - 10/2007
4	Disease Progression 01/2021 - 01/2015
4	Adenoma (Adenomas) 01/2020 - 01/2008
4	Polyps 01/2020 - 01/2008
4	Chronic Pancreatitis 01/2019 - 12/2006
4	Phlebitis 06/2018 - 11/2012
4	Cysts 05/2012 - 04/2008
3	Barrett Esophagus (Barrett's Esophagus) 01/2022 - 03/2007
3	Margins of Excision 01/2021 - 07/2012
3	Carcinogenesis 02/2020 - 06/2016
3	Liver Neoplasms (Liver Cancer) 01/2020 - 09/2014
3	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 03/2008
3	Metaplasia 01/2017 - 04/2008
3	Stomach Neoplasms (Stomach Cancer) 01/2016 - 01/2010
2	Papillomavirus Infections 01/2022 - 10/2016
2	Chondrosarcoma 01/2021 - 06/2013
2	Lymphadenopathy 01/2021 - 05/2018
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2015
2	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 01/2019
2	Colitis 11/2019 - 04/2010
2	Microscopic Colitis 11/2019 - 04/2013
2	Spontaneous Fractures (Pathological Fracture) 09/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

35	Immunoglobulin G (IgG)IBA 10/2022 - 12/2006
26	RNA (Ribonucleic Acid)IBA 10/2022 - 09/2014
19	Biomarkers (Surrogate Marker)IBA 11/2022 - 03/2010
17	Proteins (Proteins, Gene)FDA Link 11/2022 - 09/2014
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2008
9	Rituximab (Mabthera)FDA Link 01/2020 - 06/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
8	folfirinoxIBA 11/2021 - 01/2015
8	AlbuminsIBA 01/2020 - 01/2015
7	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2007
6	MucinsIBA 11/2022 - 04/2008
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2012
6	Coloring Agents (Dyes)IBA 01/2021 - 10/2009
6	Biological ProductsIBA 09/2019 - 03/2009
5	EnzymesIBA 01/2022 - 01/2012
5	DesminIBA 01/2019 - 09/2013
5	SteroidsIBA 08/2018 - 10/2009
4	LigandsIBA 11/2022 - 01/2016
4	InterferonsIBA 01/2022 - 08/2020
4	Keratins (Keratin)IBA 12/2021 - 01/2018
4	ParaffinIBA 01/2021 - 02/2011
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2022 - 01/2019
3	IntegrinsIBA 04/2022 - 09/2012
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2019
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2021 - 10/2007
3	Hematoxylin (Haematoxylon)IBA 10/2021 - 10/2007
3	Histocompatibility Antigens Class IIBA 01/2021 - 01/2016
3	AntigensIBA 01/2021 - 01/2014
3	Denosumab FDA Link 12/2020 - 01/2016
3	MicroRNAs (MicroRNA)IBA 10/2020 - 06/2016
3	Brachyury protein (Brachyury)IBA 01/2020 - 01/2011
3	CollagenIBA 01/2020 - 12/2015
3	AntibodiesIBA 01/2020 - 01/2014
3	ChromatinIBA 01/2019 - 02/2007
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2014
3	Phosphotransferases (Kinase)IBA 01/2019 - 11/2014
3	Pharmaceutical PreparationsIBA 01/2016 - 04/2010
2	AgrinIBA 01/2022 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2015
2	Nucleic AcidsIBA 01/2022 - 11/2014
2	ElementsIBA 01/2022 - 01/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 01/2021 - 02/2011
2	HLA-A Antigens (HLA-A)IBA 01/2021 - 01/2019
2	Leucovorin (Folinic Acid)FDA Link 01/2021 - 07/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 07/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 07/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2020
2	Circular RNAIBA 02/2020 - 01/2019
2	ChemokinesIBA 01/2020 - 01/2019
2	theasinensin AIBA 01/2020 - 01/2008
2	GlucocorticoidsIBA 11/2019 - 01/2012
2	infigratinibIBA 01/2019 - 01/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 01/2017

Therapy/Procedure

36	Therapeutics 11/2022 - 01/2009
9	Neoadjuvant Therapy 11/2022 - 11/2012
7	Drug Therapy (Chemotherapy) 11/2022 - 09/2012
5	Pancreatectomy 01/2022 - 01/2008
5	Immunotherapy 10/2021 - 01/2016
3	Adjuvant Chemotherapy 01/2021 - 06/2013
3	Pancreaticoduodenectomy 12/2019 - 01/2008
2	Hepatectomy 01/2021 - 10/2009